Ideaya Biosciences Inc
IDYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.52B
Close$
$-1.63
104.5% downside
Current Fair Value
104.5% downsideOvervalued by 104.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.52 Billion |
|---|---|
| Enterprise Value | $3.39 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | -0.09 |
| Outstanding Shares | 88,699,754 |
Return
| Return on Equity | -14.94% |
|---|---|
| Return on Assets | -13.59% |
| Return on Invested Capital | -19.12% |
Valuation & Multiples
| P/E Ratio | -23.41 |
|---|---|
| PEG | -61.61 |
| Price to Sales | 18.33 |
| Price to Book Ratio | 3.67 |
| Enterprise Value to Revenue | 15.04 |
| Enterprise Value to EBIT | -18.35 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.98
Average shareholder expectationRevenue Estimate
$4.68 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
$7.98 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 78.51% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.33%▼ 106.68% |
|---|---|
| Total Invested | $10.92M▼ 99.65% |
| Investors Holding | 12▼ 254.00% |
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata